DBeQ , ≥99% , 177355-84-9
Synonym(s):
JRF 12;N2,N4-dibenzylquinazoline-2,4-diamine
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB319.20 | In Stock |
|
| 10mg | RMB527.20 | In Stock |
|
| 25mg | RMB919.20 | In Stock |
|
| 50mg | RMB1599.20 | In Stock |
|
| 100mg | RMB2639.20 | In Stock |
|
| 250mg | RMB5599.20 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 149 °C |
| Boiling point: | 573.1±52.0 °C(Predicted) |
| Density | 1.259±0.06 g/cm3(Predicted) |
| storage temp. | room temp |
| solubility | DMSO: ≥20mg/mL |
| form | powder |
| pka | 7.78±0.30(Predicted) |
| color | white to beige |
| Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months. |
| InChIKey | QAIMUUJJAJBPCL-UHFFFAOYSA-N |
| CAS DataBase Reference | 177355-84-9 |
Description and Uses
DBeQ (177355-84-9) is a potent, selective and reversible inhibitor of the AAA-ATPase p97 (ATPase associated with diverse cellular activities). Ki=3.2 μM. DBeQ blocks ubiquitin-dependent protein clearance pathways. Cell permeable.
The ATPase p97 is an ubiquitin-selective chaperone known to play a critical role in the degradation of misfolded membrane and secretory proteins and has been linked to various cellular processes that require unfolding and disassembly of protein complexes. DBeQ is a selective, reversible, and ATP-competitive inhibitor of the ATPase p97 (Ki = 3.2 μM; IC50 = 1.5 μM). It does not exhibit activity when tested against a panel 170 protein kinases at concentrations as high as 15 μM. At 10 μM it blocks endoplasmic reticulum-associated degradation, impairing the autophagy pathway and promoting the activation of caspase-3 and -7 in cancer cells.[Cayman Chemical]
